Gastroenteritis resident survival guide: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{CMG}}; {{AE}}{{MehdiP}} ==Overview== ==Patient evaluation== ===Initial evaluation:=== Shown below is an algorithm depicting the initial management of acute diarrhe...")
 
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{SI}}
{{CMG}}; {{AE}}{{MehdiP}}
{{CMG}}; {{AE}}{{MehdiP}}
==Overview==
==Overview==

Revision as of 20:51, 1 March 2017

WikiDoc Resources for Gastroenteritis resident survival guide

Articles

Most recent articles on Gastroenteritis resident survival guide

Most cited articles on Gastroenteritis resident survival guide

Review articles on Gastroenteritis resident survival guide

Articles on Gastroenteritis resident survival guide in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Gastroenteritis resident survival guide

Images of Gastroenteritis resident survival guide

Photos of Gastroenteritis resident survival guide

Podcasts & MP3s on Gastroenteritis resident survival guide

Videos on Gastroenteritis resident survival guide

Evidence Based Medicine

Cochrane Collaboration on Gastroenteritis resident survival guide

Bandolier on Gastroenteritis resident survival guide

TRIP on Gastroenteritis resident survival guide

Clinical Trials

Ongoing Trials on Gastroenteritis resident survival guide at Clinical Trials.gov

Trial results on Gastroenteritis resident survival guide

Clinical Trials on Gastroenteritis resident survival guide at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Gastroenteritis resident survival guide

NICE Guidance on Gastroenteritis resident survival guide

NHS PRODIGY Guidance

FDA on Gastroenteritis resident survival guide

CDC on Gastroenteritis resident survival guide

Books

Books on Gastroenteritis resident survival guide

News

Gastroenteritis resident survival guide in the news

Be alerted to news on Gastroenteritis resident survival guide

News trends on Gastroenteritis resident survival guide

Commentary

Blogs on Gastroenteritis resident survival guide

Definitions

Definitions of Gastroenteritis resident survival guide

Patient Resources / Community

Patient resources on Gastroenteritis resident survival guide

Discussion groups on Gastroenteritis resident survival guide

Patient Handouts on Gastroenteritis resident survival guide

Directions to Hospitals Treating Gastroenteritis resident survival guide

Risk calculators and risk factors for Gastroenteritis resident survival guide

Healthcare Provider Resources

Symptoms of Gastroenteritis resident survival guide

Causes & Risk Factors for Gastroenteritis resident survival guide

Diagnostic studies for Gastroenteritis resident survival guide

Treatment of Gastroenteritis resident survival guide

Continuing Medical Education (CME)

CME Programs on Gastroenteritis resident survival guide

International

Gastroenteritis resident survival guide en Espanol

Gastroenteritis resident survival guide en Francais

Business

Gastroenteritis resident survival guide in the Marketplace

Patents on Gastroenteritis resident survival guide

Experimental / Informatics

List of terms related to Gastroenteritis resident survival guide

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]

Overview

Patient evaluation

Initial evaluation:

Shown below is an algorithm depicting the initial management of acute diarrhea is based on the 2001 IDSA practice guidelines for the management of infectious diarrhea.[1]

 
 
 
 
Characterize the symptoms:

❑ Onset
❑ Duration
❑ Pattern (continuous or intermittent)
❑ Stool characteristic (watery, bloody, mucous or greasy)
❑ Frequency of bowel movements
❑ Dysenteric symptoms (fever, tenesmus, blood and/or pus in stool)


Associated symptoms:
Abdominal pain
Nausea and vomiting
❑ Weight loss


Epidemiological factors:
❑ Travel
❑ Food (raw meat, eggs, shellfish, unpasteurized cheese or milk)
❑ Outbreaks
❑ Sexual history
❑ Day care attendance
❑ Previous evaluations
❑ Medications, radiation therapy or surgery
❑ Underlying medical condition (cancer, diabetes, hyperthyroidism or AIDS)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Examine the patient:

Temperature
Pulse
Blood pressure
❑ Respiratory rate
❑ Signs of volume depletion (decreased skin turgor, dry mucosa)
❑ Abdominal tenderness

❑ Level of consciousness
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assessment of volume status
General conditionNormalIrritable/less active*Lethargic/comatose§
EyesNormalSunken -
MucosaNormalDry -
ThirstNormalThirstyUnable to drink§
Radial pulseNormalLow volume*Absent/ uncountable§
Skin turgorNormalReduced -

† Some dehydration = At least two signs, including at least one key sign (*) are present.

‡ Severe dehydration = Signs of “some dehydration” plus at least one key sign (§) are present.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No dehydration
 
Some dehydration
 
Severe dehydration
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Start altered diet

❑ Stop lactose products
❑ Avoid alcohol and high osmolar supplements
❑ Drink 8-10 large glasses of clear fluids (Fruit juices, soft drinks etc)
❑ Eat frequent small meals (Rice, potato, banana, pastas etc)


Can start oral rehydration therapy (ORT) for replacement of stool losses
 
❑ Start ORT at a volume of 50-100 mL/kg
❑ Start altered diet
❑ Reassess status every 4 hr
 
❑ Start IV fluids: Ringer lactate at 30ml/kg in the first 1/2hr and 70ml/kg for the next 2 1/2 hr, if unavailable use normal saline
CBC
Electrolytes
❑ Assess status every 15 mins until strong pulse felt and then every 1 hr
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patient stable and able to drink
❑ Start ORT at a volume of 100 mL/kg over 4 hour
❑ Calculate the continuing stool and emesis losses every hour for additional maintenance ORT therapy
❑ Reassess status every 4 hr
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hemodynamic stabilized
Proceed to Diagnosis and Management
 
 

Management:



 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Passage of ≥3 unformed stools in 24 h
+
An enteric symptom (nausea, vomiting, abdominal pain/cramps, tenesmus, fecal urgency, moderate to severe flatulence)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Watery diarrhea
± Vomiting
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dysenteric diarrhea (passage of grossly bloody stools)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mild Illness
 
 
 
 
 
 
Moderate to Severe
 
 
 
 
 
 
 
No or low-grade fever(≤100°F)
 
 
 
Severe illness with fever≥(101°F) in a single case (not outbreak)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hydration only
May use loperamide 4 mg initially to control stooling
 
Travel associated
 
 
 
 
Non travel associated
 
 
 
 
 
 
 
 
 
Non travel associated
 
 
Travel associated
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Antibiotic therapy
 
No or low-grade fever (≤100°F)
 
 
 
Fever (≥101°F)
 
 
 
 
 
 
 
 
 
 
 
 
Empiric treatment
Azithromycin 1 g in single dose OR
500 mg once daily for 3 days
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<72 h duration
 
≥72 h duration
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Loperamide therapy for 48 h
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Microbiologic assessment and appropriate treatment
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Persistent diarrhea (14–30 days)
should be worked up by culture and/or culture independent microbiologic assessment, then treatment with anti microbial agent directed to cause
 
 
 
 
 
 
 
 
 
 

Illness severity:

  • Severe: Total disability due to diarrhea;
  • Moderate: Able to function but with forced change in activities due to illness;
  • Mild: No change in activities

General principles for treatment

  • Rehydration with a balanced sodium-glucose solution is The first step for treatment. Oral rehydration solution (ORS) has reduced infant mortality in developing countries by at least 50%.[2] ORS has no effect on disease course however, it's valuable to treat dehydration.
  • For infants and the elderly with severe travelers diarrhea (TD) and in anyone who develops profuse cholera-like watery diarrhea, balanced ORS and medical evaluation are advised.
  • For most otherwise healthy adults with TD, formal ORS is not needed as they can keep up with fluid losses by taking in salty soups, fruit juices and carbohydrates to provide enough compensation. [3]
  • In severe diarrhea, a balanced ORS can usually be found at a local pharmacy with sodium of 60–75 mEq/l and glucose of 75–90 mmol/l for replacing salt and water. [4]
  • Bismuth subsalicylates (BSSs) can be administered to control rates of passage of stool and may help travelers function better during bouts of mild to moderate illness. The recommended dose of BSS for therapy of acute diarrhea is 30 ml (525 mg) of liquid formulation or two tablets (263 mg per tablet) chewed well each 30–60 min not to exceed eight doses in 24 h. The drug will cause black stools and black tongues.
  • In patients receiving antibiotics for TD, adjunctive loperamide therapy can be administered to decrease duration of diarrhea and increase chance for a cure. The recommended dose of loperamide for therapy for adults with diarrhea is 4 mg initially followed by 2 mg after subsequently passed watery stools not to exceed 8 mg per day. Loperamide is not given for more than 48 h. The most valuable use of loperamide in the self-treatment of TD is as a combination drug with antibacterial drugs where the antimotility drug quickly reduces the number of diarrhea stools passed while the antibiotic cures the enteric infection. [5]
  • empiric anti-microbial therapy for routine acute diarrheal infection, except in cases of TD where the likelihood of bacterial pathogens is high enough to justify the potential side effects of antibiotics.
  • Use of antibiotics for community-acquired diarrhea should be discouraged as epidemiological studies suggest that most community-acquired diarrhea is viral in origin (norovirus, rotavirus, and adenovirus) and is not shortened by the use of antibiotics.
  • Antibiotics shorten the overall duration of moderate-to-severe TD to a little over 24 h and are recommended in TD. [6][7] The following table summarizes the recommended antibiotics for TD.
Antibiotic treatment recommendations
Antibiotic Dose Duration
Levofloxacin 500 mg PO Single dose or 3 days
Ciprofloxacin 750 mg PO Single dose
500 mg PO 3 days
Ofloxacin 400 mg PO Single dose b or 3 days
Azithromycin 1000 mg PO Single dose
500 mg PO 3 days
Rifaximin 200 mg PO, TID 3 days

: If symptoms are not resolved after 24 h, complete a 3-day course of antibiotics.

: Preferred regimen for dysentery or febrile diarrhea.

: Do not use if clinical suspicion for Campylobacter , Salmonella , Shigella , or other causes of invasive diarrhea.

  1. Guerrant RL, Van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV; et al. (2001). "Practice guidelines for the management of infectious diarrhea". Clin Infect Dis. 32 (3): 331–51. doi:10.1086/318514. PMID 11170940.
  2. Victora CG, Bryce J, Fontaine O, Monasch R (2000). "Reducing deaths from diarrhoea through oral rehydration therapy". Bull. World Health Organ. 78 (10): 1246–55. PMC 2560623. PMID 11100619.
  3. Casburn-Jones AC, Farthing MJ (2004). "Management of infectious diarrhoea". Gut. 53 (2): 296–305. PMC 1774945. PMID 14724167.
  4. Duggan C, Fontaine O, Pierce NF, Glass RI, Mahalanabis D, Alam NH, Bhan MK, Santosham M (2004). "Scientific rationale for a change in the composition of oral rehydration solution". JAMA. 291 (21): 2628–31. doi:10.1001/jama.291.21.2628. PMID 15173155.
  5. DuPont HL, Ericsson CD, Farthing MJ, Gorbach S, Pickering LK, Rombo L, Steffen R, Weinke T (2009). "Expert review of the evidence base for self-therapy of travelers' diarrhea". J Travel Med. 16 (3): 161–71. doi:10.1111/j.1708-8305.2009.00300.x. PMID 19538576.
  6. De Bruyn G, Hahn S, Borwick A (2000). "Antibiotic treatment for travellers' diarrhoea". Cochrane Database Syst Rev (3): CD002242. doi:10.1002/14651858.CD002242. PMID 10908534.
  7. Adachi JA, Ericsson CD, Jiang ZD, DuPont MW, Martinez-Sandoval F, Knirsch C, DuPont HL (2003). "Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico". Clin. Infect. Dis. 37 (9): 1165–71. doi:10.1086/378746. PMID 14557959.